INTS
INTENSITY THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.28
−1.70%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-121.2%
Return on equity
-96.9%
Return on assets
-123.4%
Return on invested capital
0.00x
Asset turnover
-$9.0M
Cash from operations
$2.92
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026